Accepted at 6:44 p.m. Jan, 12, 2025 by Eli.Tanenbaum
Bulk Suggestion Bulk ID: Eli.Tanenbaum/01.12.25-06:55AM
Author: Eli.Tanenbaum
Related Note: 1473986243860 1
Rationale for change

changing formerly immune thrombocytopenic purpura to idiopathic thrombocytopenic purpura

Extra Extra
Text
What is the first-line pharmacological treatment for symptomatic immune thrombocytopenia (ITP)?

{{c1::Corticosteroids (e.g., dexamethasone or prednisone)}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid




Sketchy
Watch Quantitative Platelet Disorders
Sketchy 2








Watch Bleeding Disorders: Platelet Disorders DDx
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Immune Thrombocytopenic Purpura (ITP)
Physeo
Bootcamp
Watch associated Bootcamp video - Platelets: Platelet Disorders
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::05_Platelet_Disorders::Extra #AK_Step1_v12::#Physeo::^physeo_image_update !AK_UpdateTags::AnKing_Image::Mujeeb::Platelet_disorders #AK_Step1_v12::#Pixorize::01_Biochemistry::18_Platelet_Disorders::05_Immune_Thrombocytopenic_Purpura_(ITP) #AK_Step2_v12::#AMBOSS::CGaqYm #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::03_Platelet_Disorders #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::01_Thrombocytopenia #AK_Step1_v12::^Other::^HighYield::4-LowerYield #PANCE::EOR::IM #AK_Step3_v12::#UWorld::12555 #AK_Step2_v12::#NBME::Form14::Section_3 #AK_Step1_v12::#Pathoma::04_Hemostasis::01_Primary_Hemostasis_&_Related_Bleeding_Disorders #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::17_Platelet_disorders::*Immune_Thrombocytopenic_Purpura !AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Platelet_disorders #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::01_Primary_Hemostasis #AK_Step2_v12::#AMBOSS::#Self-Assessment::2024::Block-2 #AK_Step3_v12::#UWorld::5297 !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-Hematology #AK_Step2_v12::#AMBOSS #AK_Step1_v12::^Systems::HemeOnc::Hematology #PANCE::EOR::PEDS #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::02_Bleeding_Disorders:_Platelet_Disorders_DDx #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step2_v12::#NBME